<DOC>
	<DOCNO>NCT00488917</DOCNO>
	<brief_summary>The purpose study determine role new biomarkers diagnosis sepsis critically-ill patient liver failure correlate prognosis patient parameter endothelial function lipid metabolism .</brief_summary>
	<brief_title>Sepsis , Endothelial Function , Lipids Critically Ill Patients With Liver Failure ( SELLIFA Study )</brief_title>
	<detailed_description>Early diagnosis sepsis may difficult patient severe liver failure absence usual warning clinical sign . Furthermore , routine laboratory test like blood leucocyte count serum c-reactive protein may mislead patient . A great interest take identification sepsis biomarkers sepsis-induced alteration inflammation cascade , whose expression independent liver function . Determination biomarker may useful tool early diagnosis sepsis may prognostic significance patient liver failure . Septic complication patient liver failure may induce disruption liver microcirculation , regulate several factor act endothelial liver stellate cell . Furthermore , generation reactive oxygen specie result oxidative stress lipid , protein , DNA . Lipid peroxidation may contribute hepatocellular injury activation systemic inflammation cascade . Both endothelial dysfunction alteration lipid metabolism may role prognosis liver disease complication . The purpose prospective observational study determine role new biomarkers diagnosis sepsis critically-ill patient liver failure correlate prognosis patient parameter endothelial function lipid metabolism . In addition , porto-systemic gradient parameter determine patient plan transjugular intra-hepatic porto-systemic shunt ( TIPSS ) . An overall number 120 patient enrol . According mode presentation , plan number patient different study group follow : 70 patient chronic liver failure acute chronic liver failure ; 20 patient acute liver failure ; 30 patient post-liver transplantation .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Sepsis</mesh_term>
	<mesh_term>Toxemia</mesh_term>
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Critical Illness</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Liver Failure</mesh_term>
	<criteria>Inclusion Criteria : All consecutive patient diagnosis chronic liver failure , acute chronic liver failure , acute liver failure , postliver transplantation ; Adult patient age 18 year , less 85 ; Admission ICU expect period &gt; 24 hour elective admission TIPSS placement ; Informed consent patient nearest relative . Exclusion Criteria : Age le 18 year 85 ; Pregnancy , include HELLP syndrome ; Active malignancy metastasis ( localised hepatocellular carcinoma exclusion criterion ) ; Systemic chemotherapy last 4 week ( transarterial chemoembolisation localise hepatocellular carcinoma exclusion criterion ) ; Acquired immunodeficiency syndrome antiretroviral therapy ; Refusal patient nearest relative .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Liver cirrhosis</keyword>
	<keyword>acute liver failure</keyword>
	<keyword>liver transplantation</keyword>
	<keyword>sepsis , infection</keyword>
	<keyword>endothelium</keyword>
	<keyword>lipid</keyword>
	<keyword>diagnosis</keyword>
	<keyword>prognosis</keyword>
</DOC>